Skip to main content

22-01-2018 | Image

Figure 4 : Study design to compare the efficacy of reference drugs and biosimilars.

Switching, as has been carried out in clinical trials of some biosimilars, is compared with substitution involving single or multiple switches, as potential study designs to support the FDA designation of interchangeability. Switch studies are not required for approval by the EMA.

Image Credits